45 related articles for article (PubMed ID: 29095060)
1. Clinical utility gene card for: Familial platelet disorder with associated myeloid malignancies.
Ripperger T; Tawana K; Kratz C; Schlegelberger B; Fitzgibbon J; Steinemann D
Eur J Hum Genet; 2016 Aug; 24(8):. PubMed ID: 26813945
[No Abstract] [Full Text] [Related]
2. Molecular testing for acute myeloid leukemia.
Qin D
Cancer Biol Med; 2021 Aug; 19(1):4-13. PubMed ID: 34347394
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Value of TP53 Mutations in Adult Acute Myeloid Leukemia: A Meta-Analysis.
Qin G; Han X
Transfus Med Hemother; 2023 Jun; 50(3):234-244. PubMed ID: 37435002
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemia.
Damnernsawad A; Bottomly D; Kurtz SE; Eide CA; McWeeney SK; Tyner JW; Nechiporuk T
Haematologica; 2022 Jan; 107(1):77-85. PubMed ID: 33375770
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of decitabine in combination with standard-dose cytarabine, aclarubicin hydrochloride, and granulocyte colony-stimulating factor in the treatment of young patients with newly diagnosed acute myeloid leukemia.
Dou L; Xu Q; Wang M; Xiao Y; Cheng L; Li H; Huang W; Mei J; Jing Y; Bo J; Liu D; Yu L
Onco Targets Ther; 2019; 12():5013-5023. PubMed ID: 31303761
[No Abstract] [Full Text] [Related]
6. Chronic myelomonocytic leukemia associated with myeloid sarcomas and
Matanes F; AbdelAzeem BMA; Shah G; Reddy V; Saad A; Papadantonakis N
Ther Adv Hematol; 2019; 10():2040620719854596. PubMed ID: 31217941
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib Dose Recommendation in Acute Myeloid Leukemia Based on Exposure-FLT3 Relationship.
Liu T; Ivaturi V; Sabato P; Gobburu JVS; Greer JM; Wright JJ; Smith BD; Pratz KW; Rudek MA;
Clin Transl Sci; 2018 Jul; 11(4):435-443. PubMed ID: 29702736
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms.
Patel U; Luthra R; Medeiros LJ; Patel KP
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S62-S74. PubMed ID: 28760304
[TBL] [Abstract][Full Text] [Related]
9. Emerging molecular predictive and prognostic factors in acute myeloid leukemia.
McCurdy SR; Levis MJ
Leuk Lymphoma; 2018 Sep; 59(9):2021-2039. PubMed ID: 29095060
[TBL] [Abstract][Full Text] [Related]
10. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
11. Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutations.
Shin SY; Lee ST; Kim HJ; Cho EH; Kim JW; Park S; Jung CW; Kim SH
Oncotarget; 2016 Aug; 7(34):54825-54837. PubMed ID: 27359055
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.
Green CL; Koo KK; Hills RK; Burnett AK; Linch DC; Gale RE
J Clin Oncol; 2010 Jun; 28(16):2739-47. PubMed ID: 20439648
[TBL] [Abstract][Full Text] [Related]
13. The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
Duncavage EJ; Tandon B
Int J Lab Hematol; 2015 May; 37 Suppl 1():115-21. PubMed ID: 25976969
[TBL] [Abstract][Full Text] [Related]
14. DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML.
Ma J; Dunlap J; Paliga A; Traer E; Press R; Shen L; Fan G
Leuk Lymphoma; 2018 Aug; 59(8):1938-1948. PubMed ID: 29165010
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]